Gathsaurie Neelika Malavige Selected Research

Severe Dengue

1/2021	Urinary leukotrienes and histamine in patients with varying severity of acute dengue.
11/2020	Risk Factors for Elevated Serum Lipopolysaccharide in Acute Dengue and Association with Clinical Disease Severity.
1/2020	Dysfunctional Innate Immune Responses and Severe Dengue.
1/2020	Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.
12/2018	Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection.
11/2017	Mathematical modelling and a systems science approach to describe the role of cytokines in the evolution of severe dengue.
10/2015	Polymorphisms of Transporter Associated with Antigen Presentation, Tumor Necrosis Factor-α and Interleukin-10 and their Implications for Protection and Susceptibility to Severe Forms of Dengue Fever in Patients in Sri Lanka.
10/2014	Dengue NS1 antigen as a marker of severe clinical disease.
7/2013	Serum IL-10 as a marker of severe dengue infection.
1/2013	Suppression of virus specific immune responses by IL-10 in acute dengue infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gathsaurie Neelika Malavige Research Topics

Disease

28	Dengue (Dengue Fever) 01/2022 - 01/2011
26	Infections 10/2022 - 03/2007
12	Severe Dengue 01/2021 - 01/2011
9	Fever (Fevers) 01/2022 - 01/2012
4	COVID-19 08/2021 - 11/2020
3	Shock 01/2022 - 01/2011
2	Pleural Effusion (Pleural Effusions) 01/2022 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2022 - 10/2018
2	Liver Neoplasms (Liver Cancer) 11/2018 - 07/2018
1	Vomiting 01/2022
1	Headache (Headaches) 01/2022
1	Hemorrhage 01/2022
1	Reinfection 08/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Inflammation (Inflammations) 01/2020
1	Hemolysis 07/2018
1	Neoplasms (Cancer) 07/2018
1	Ascites 01/2018
1	Hypersensitivity (Allergy) 01/2017
1	Measles 01/2017
1	Mumps 01/2017
1	Necrosis 01/2017
1	Rabies (Hydrophobia) 01/2017
1	Rubella (German Measles) 01/2017
1	Tetanus 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Diphtheria 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 07/2015

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2022 - 01/2012
7	AntibodiesIBA 01/2022 - 11/2014
5	Immunoglobulin G (IgG)IBA 01/2022 - 11/2014
5	Platelet Activating FactorIBA 01/2022 - 02/2015
5	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2012
4	VaccinesIBA 07/2022 - 12/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	AntigensIBA 03/2022 - 10/2014
3	LeukotrienesIBA 01/2022 - 01/2017
3	Peptides (Polypeptides)IBA 01/2020 - 04/2015
2	rupatadineIBA 01/2022 - 01/2018
2	ChAdOx1 nCoV-19IBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 07/2015
2	Neutralizing AntibodiesIBA 08/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 07/2013
2	Antiviral Agents (Antivirals)IBA 11/2020 - 12/2013
2	ChemokinesIBA 11/2020 - 01/2020
2	Dengue VaccinesIBA 01/2020 - 01/2015
2	LipidsIBA 01/2020 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018 - 01/2016
2	Viral ProteinsIBA 01/2017 - 01/2013
2	Immunoglobulin M (IgM)IBA 07/2015 - 11/2014
2	EpitopesIBA 01/2011 - 01/2008
1	BIBP COVID-19 vaccineIBA 10/2022
1	delta Opioid Receptors (delta Opioid Receptor)IBA 10/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	ProstaglandinsIBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	Blocking AntibodiesIBA 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2021
1	CreatinineIBA 01/2021
1	Leukotriene E4IBA 01/2021
1	LipopolysaccharidesIBA 11/2020
1	ProcalcitoninIBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018
1	AlginatesIBA 11/2018
1	gingerolIBA 11/2018
1	Durapatite (Hydroxylapatite)IBA 11/2018
1	Transaminases (Aminotransferases)IBA 10/2018
1	Pharmaceutical PreparationsIBA 07/2018
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2018
1	KRN 7000 (KRN7000)IBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	platelet activating factor receptorIBA 01/2018
1	Phospholipases (Phospholipase)IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	Bovine Serum AlbuminIBA 01/2017
1	GelatinIBA 01/2017
1	Excipients (Suspending Agents)IBA 01/2017
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Angiopoietin-2IBA 01/2017
1	Tryptases (Tryptase)IBA 01/2017
1	Secretory Phospholipases A2IBA 01/2017
1	TransferasesIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015
1	ImmunosorbentsIBA 07/2015
1	Granzymes (Granzyme)IBA 04/2015
1	Zonula Occludens-1 ProteinIBA 02/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2014
1	Interleukin-3 (Interleukin 3)IBA 01/2012
1	Interleukin-13IBA 01/2012
1	Interleukin-17 (Interleukin 17)IBA 01/2012
1	Immunologic Factors (Immunomodulators)IBA 01/2012
1	Interleukin-2 (IL2)IBA 01/2012
1	HLA-A31 antigenIBA 01/2011

Therapy/Procedure

1	Therapeutics 07/2018